Colgate-Palmolive (CL) Earnings Date & Reports

Key Takeaways

• Colgate-Palmolive is expected to report third-quarter 2026 results before the market opens on or around October 23, 2026.
• Consensus estimates point to earnings per share (EPS) of roughly $0.93, up from $0.91 in the year-ago quarter.
• Wall Street models revenue near $5.34 billion, compared with $5.13 billion in Q3 2025.
• Investors will focus on how higher raw-material and tariff costs, expected to peak in the second half, affect gross margin.
• Emerging markets and the Hill's Pet Nutrition business remain the key growth drivers, while North America volumes stay soft.

Earnings Context and Why It Matters

Colgate-Palmolive's third-quarter report arrives at a pivotal moment. The company entered 2026 with improving organic sales and disciplined pricing, but management has flagged roughly $300 million of incremental raw-material and logistics cost pressure tied to tariffs and elevated commodity prices. In the second quarter, Colgate delivered Base Business (non-GAAP) EPS of $0.99 and raised its full-year gross-margin outlook to "roughly flat," signaling that cost headwinds are now expected to be most severe in the back half. This quarter will test whether pricing, productivity programs, and emerging-market demand can offset those pressures while North America navigates retailer inventory destocking and weaker volumes.

Earnings Expectations

Analysts are looking for Colgate-Palmolive to report third-quarter EPS of approximately $0.93, a modest increase from $0.91 in the same period a year earlier. Revenue is expected to come in near $5.34 billion, up from $5.13 billion in Q3 2025, implying continued low-single-digit growth. On an organic basis, which excludes the impact of foreign exchange and divestitures, consensus models point to growth in the low-single-digit range, consistent with the company's full-year guidance of 1% to 4% organic sales growth.

Key metrics in focus include gross margin, where management has guided to a roughly flat full-year result after a second-quarter expansion of roughly 100 basis points, and advertising spend, which rose double digits in Q2 as the company funds premium, science-led innovation. Investors will also watch Hill's Pet Nutrition, where the exit from private-label pet food has been a recurring volume headwind, and North America, where shipments declined about 3% last quarter amid retail destocking.

Colgate has a strong track record of meeting or beating estimates, having topped EPS consensus in each of its recent quarters, typically by low-single-digit percentages. That history raises the bar for another upside surprise.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is built to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For those tracking consumer staples names like Colgate-Palmolive ahead of earnings, the AI Screener offers a structured way to identify potential setups and monitor sector momentum.

Market Reaction and Investor Sentiment

Sentiment heading into the quarter is cautiously constructive but mixed. Colgate-Palmolive shares have outperformed the broader consumer staples group in 2026, supported by resilient demand for oral care and pet nutrition and a strong emerging-markets footprint. However, investors remain attentive to margin risk, with management warning that raw-material and tariff cost pressure will peak in the back half of the year, driven in part by oil prices around $90 per barrel.

The primary risk factors ahead of the print are a continuation of North American volume softness and any sign that input-cost inflation outpaces the company's pricing and productivity offsets. Conversely, sustained momentum in Latin America and Asia Pacific, plus a stable gross margin, could reinforce confidence in the company's full-year outlook.

Forward Outlook and Key Factors to Monitor

Following the report, the most important signal will be management's updated commentary on full-year guidance. Colgate has maintained its 2026 outlook for net sales growth of 2% to 6% and organic sales growth of 1% to 4%, alongside low- to mid-single-digit Base Business EPS growth. Any adjustment to gross-margin expectations—currently guided to "roughly flat"—will be closely scrutinized.

Investors should monitor the trajectory of raw-material and logistics costs, particularly resins, petrochemicals, and fats and oils, where prices have risen more than 20% year over year. The company's Strategic Growth and Productivity Program is expected to deliver $200 million to $300 million in annual savings once fully implemented by 2028, but the bulk of those benefits arrive later.

On the demand side, watch whether North America stabilizes as retailer destocking eases, and whether emerging markets such as India, Brazil, and Mexico sustain their mid-single-digit growth. Hill's Pet Nutrition, excluding the private-label exit, remains a focal point given its roughly 4% organic growth. Finally, continued elevated advertising investment signals management's confidence in brand-building, but it will also keep near-term margin expansion in check.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations